Kenvue Inc.
Kenvue Appoints New Directors and Enters Cooperation Agreement with Starboard
Summary
Kenvue Inc. has appointed three new directors to its Board of Directors as part of a cooperation agreement with Starboard Value LP. The agreement, effective immediately, expands the board size from 11 to 14 directors and includes provisions for board nominations at the 2025 Annual Meeting, standstill agreements, and committee assignments for the new directors. Starboard also agreed to withdraw its previously nominated director slate and vote its shares in favor of Kenvue's nominees. The agreement aims to strengthen the board with complementary expertise and facilitate the pursuit of growth and profitability.
Profitelligence Alerts
Get alerts for KVUE
Be first to know when Kenvue Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Official SEC Documents
Advertisement